Trial Validates First Treatment to Actually Improve Alzheimer’s Disease

“In an FDA approved study, 78% of patients with mild cognitive impairment or early Alzheimer’s improved over their personal baseline after six months of this non-invasive treatment,” said Cerezen’s Chief Medical Advisor, Jack Juni, M.D.

Europe Approves New Alzheimer’s Treatment Why is the U.S. Still Waiting?

Cerezen™, a new treatment which has been shown to reverse symptoms of Alzheimer’s in some cases, was certified in the EU this month.